HGBCL

Clinical trials for HGBCL explained in plain language.

Never miss a new study

Get alerted when new HGBCL trials appear

Sign up with your email to follow new studies for HGBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial offers hope for Tough-to-Treat lymphomas

Disease control Recruiting now

This early-stage study is testing an experimental drug called MDX2003 for people with several types of B-cell lymphoma that have come back or stopped responding to at least two prior treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. It will…

Matched conditions: HGBCL

Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

HGBCL

Get alerted when new HGBCL trials appear

New drug trial offers hope for Tough-to-Treat lymphomas